Corvus Pharmaceuticals Inc (CRVS)

Income Before Tax

-$17.25M

Quarterly · Period ending: · USD

CRVS logo

CRVS Income Before Tax

Latest reported-$17.25M
CRVS Quarterly Pre-Tax Income (-$154.00K → -$17.25M)
High-resolution chart · PNG

CRVS income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Corvus Pharmaceuticals Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-17,250,000
-13,692,000
-12,321,000
-10,157,000
-7,998,000
15,193,000
-12,113,000
-40,217,000
-4,262,000
-5,701,000
-6,653,000
-6,000,000
-6,503,000
-7,873,000
-9,816,000
-14,831,000
-8,363,000
-8,297,000
-9,236,000
-10,673,000
-11,752,000
-11,580,000
27,347,000
-9,796,000
-10,611,000
-12,935,000
-11,047,000
-11,004,000
-12,978,000
-11,643,000
-10,509,000
-10,498,000
-11,631,000
-14,301,000
-11,929,000
-12,717,000
-14,981,000
-16,036,000
-11,086,000
-10,297,000
-8,645,000
-6,347,000
-6,039,000
-3,151,000
-20,232,000
-1,913,000
-154,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.